
Learn more about our collaboration with the APA: osmind.org/blog/osmind-apa-c…
✓The premier technology platform for breakthrough mental health treatment and research.

Learn more about our collaboration with the APA: osmind.org/blog/osmind-apa-c…

🔜 🧠 “We are about to enter the era of interventional psychiatry, transforming the field of psychiatry.” — Tom Insel, former NIMH Director, at a recent psychedelic science conference. We have invested in many of these new modalities: transcranial focused ultrasound (Sanmai), minimally invasive deep brain stimulation and vagus nerve stimulation (Neurobionics), brain-computer-interfaces (Neuralink), auditory dream engineering (Dust), psychedelic-assisted therapy (atai/Lilly), and real-world-data collection for all (Osmind). Insel also co-authored a Nature paper with Osmind defining the field: nature.com/articles/s44220-0… + summary: osmind.org/interventional-ps… Interventional psychiatry companies: • tFUS: Sanm.ai/technology • Endovascular DBS: Neurobionics.io • BCI: Neuralink.com • Dream engineering: DUST.systems • Psychedelics: ataibeckley.com P.S. Underfunded: “From 2002-2013, the NIMH did not receive any funding applications for psychedelics. It was all funded and legitimized by philanthropy.” P.S.S. Needed: “The World Health Organization (WHO) predicts that without significant changes, mental illness will cost the world economy $16t by 2030, making it the largest disease burden globally." — UBS: flic.kr/p/2jcRcoS We need significant changes.

Introducing Osmind Intelligence: AI for the new era of psychiatry, woven throughout the Osmind platform. It surfaces patients who may benefit from further evaluation, drafts clinical notes, suggests billing codes, and helps automate compliance workflows—with clinicians reviewing every output. Every psychiatry visit comes with clinical and administrative work that never gets billed. Osmind Intelligence is shaped by our experience supporting more than 1,000 psychiatry practices and the 1 million treatments they've delivered. It’s informed by what our in-house revenue cycle and practice operations teams have seen firsthand about where that work piles up. Every modality a practice adds brings more documentation and payer requirements. Osmind Intelligence takes on that work, so practices can grow and offer their patients more options. See Osmind Intelligence: osmind.org/ai

"The business model has to change completely. It stops being about how many people you can see per hour" Will Sauvé - CMO of @OsmindHQ - sat down with @NeuroTechX to explore how to scale #psychiatric care #neurotech #mentalHealth bit.ly/4dTkTJ9

Spravato and TMS billing and prior auths can be a headache. Osmind helps you close revenue and care gaps. Get your EHR, billing, and RCM with one in-house team that knows interventional from med management, with the metrics that beat the benchmark. So you can grow and focus on what matters.


Some people have tried three antidepressants. Five. Seven. And still haven’t found meaningful relief. That’s treatment-resistant depression (TRD), and an estimated 4 million Americans are living with it. Today, for the first time, it has its own awareness day. We’re proud to join @COMPASSPathway and leading advocacy organizations in marking #TRDawarenessday. Across the Osmind community, we see what’s possible when people with TRD reach clinicians who specialize in interventional treatment. Earlier this year, we helped define “interventional psychiatry” in Nature Mental Health, because shared language is how a field grows and how more patients find their way to it. Awareness is the first step. Earlier recognition is the next. Our mission is to help clinicians bring evidence-based treatments to the patients who need them most. If you or someone you love is living with TRD, you are not alone. #TRDawarenessday #DepressionAwarenessMonth #MentalHealth #InterventionalPsychiatry

"Anything that isn't directly related to that is something that we can potentially partner with Osmind with." - Michael Dinh, MD Revenue cycle management, charting, claims are all integrated. The alternative was two psychiatrists spending their week fighting for billing and haggling with insurance instead of being present with patients. Amast Health never had to build a back office because Osmind handles it all. Now Amast can focus on deliverying breakthrough treatments safely and profitably.

full story: osmind.org/blog/amast-health…

Amast Health built a Spravato practice from scratch, but operations consumed precious time. "The things that we didn't have a plan for yet were the things that Osmind was gonna take care of." Compliance, claims, payer contracts, and the revenue cycle required for scaling with insurance in interventional psychiatry. “ Osmind had already really positioned themselves as the EMR for interventional practices. I knew they really built out their system very well.“ Full story on Amast Health building for psychiatry's next era at the link in comments.

For two years, Sahab Yaqubi, M.D. ran his EHR in one system and his billing in another, connected by a clearinghouse and a shared folder. "The problem was that there were several systems. Here it's all one." PathWave Psychiatry now runs more than 220 encounters a month with Dr. Yaqubi as its only prescribing clinician, offering Spravato, TMS, and medication management to patients with treatment-resistant depression and anxiety. On Osmind 360, the practice collects from payers in about 26 days, ahead of the 35-day industry norm. For the first time, he can see his own revenue cycle numbers. “If you want to do simple medication management, without depending on Spravato prior authorizations, maybe other options can be helpful. But for an interventional psychiatry practice like ours, having the EHR, billing, and authorization workflows integrated in one platform has been a significant improvement” osmind.org/blog/pathwave-psy…

That's a wrap on back-to-back conferences: Behavioral Health Tech in Nashville and ASKP³ Mastering the Essentials in Denver. Thank you to everyone who stopped by our booth and to the speakers who sharpened our thinking. At BHT, our CEO Lucia Huang joined the psychedelics panel, which quickly converged on one theme: psychedelics in real-world practice will bring a level of complexity clinical trials haven't yet contemplated. Takeaways from both events: Matching patients to treatments. If multiple psychedelic therapies reach FDA approval, how will clinicians know which is right for each patient, and when? Nate Mohatt of ARPA-H made a compelling case for precision psychiatry and objective biomarkers to tailor treatment. Practice guidelines can't come soon enough. Sarah Norman shared the work BrainFutures is doing to establish them, while earning more laughs than any moderator we've seen :) Treatment is changing shape. Scott Shannon, MD, of The Wholeness Center put it well: the field is moving from three visit types (evaluations, therapy, and medication management) to complex, multi-hour treatments that combine dosing, therapy, and monitoring. In Denver, we saw it firsthand. More practices are offering ketamine, Spravato, and TMS together, and many are preparing for psychedelic treatments if and when they're approved. The field now has a shared definition. Our team recently published "Defining Interventional Psychiatry" in Nature Mental Health (link in comments). Operations set the ceiling on growth. Credentialing, prior authorizations, billing, charting, patient intake and retention, and REMS submissions all cost practices revenue and time. That last one is where Osmind comes in. As the partner to 1,000+ practices and 15+ life sciences companies, we give clinicians psychiatry's leading technology platform plus back-office services like revenue cycle management, so they can bring these treatments to the patients who need them most.

We ran a session with Rise4 to help you find and close those bottlenecks, and wrote-up a practical guide (linked in comments) on non-obvious ways to find more patients in your own panel. In a typical 300 to 400 patient panel, at least 50 to 60 patients would likely clear prior authorization for TMS or esketamine right now. Most practices go looking for new demand before they look at that. This pt. 1 of this guide, Jake Buchanan, Justin Gammill, and our own William Sauvé, MD cover: •How to find patients in your own panel •A five-part referral engine •An exit folder idea you can take with you Before you spend money on marketing or ads, start with shoring up your systems and look to your existing patient panel. Full guide: osmind.org/blog/find-tms-spr…

What breaks when your interventional psychiatry practice grows faster than the systems supporting it? More inquiries can mean more missed follow-ups. More referrals can leave teams chasing the next step. More capacity can sit unused while the same bottlenecks keep people from starting treatment.

We’re honored to have @TIME recognize Osmind as one of the World's Top Health Tech Companies of 2026! This is the second year we made this list. What makes our mission worthwhile is the people we serve—psychiatrists and nurse practioners delivering novel treatments for depression, researchers advancing psychedelic medicine, practices scaling operations with our platform. 2026 and 2027 are breakthrough years for fast-tracking psychedelic approvals. As we sail into uncharted waters, we're working hard to ensure practices can deliver them safely and profitably when the time comes. Thank you TIME and thank you to all the mental health innovators that inspire us every day!

In 2020, our co-founders, Lucia Huang and Jimmy Qian started knocking on clinic doors because they’d seen what ketamine could do for patients who'd run out of treatment options, and how hard it was for independent practices to actually offer it. That's why they built Osmind. Today, Osmind powers the largest network of interventional psychiatry practices in the country, and we're proud to sponsor @American Society of Ketamine Physicians, Psychotherapists and Practitioners (ASKP3)s Mastering the Essentials again this year. Whether you're launching your first ketamine program or scaling into Spravato and TMS, we're here to help you automate admin and capture more revenue, so you focus on what matters. Good medicine can and should be good business. Find our team at our table in Denver, September 25–27. We've got an offer just for Mastering the Essentials attendees.